SPRINGFIELD, Mo. and PETALUMA, Calif., March 8, 2006 (PRIMEZONE) -- The Department of Chemistry at Missouri State University announced today that Dr. David Osborne, Vice President of Product Development for www.dowpharmsci.com, will teach a two-day course (April 20-21) in Springfield, Missouri titled "Dermatological Product Development for Managers." This course was developed to provide a working knowledge of topical product development for managers who may be familiar with pharmaceutical development but not with dermatological products.
The course outline and registration form, http://www.dowpharm.com/derm-product-dev-r1.asp indicates that a solid basic review of the skin and formulations for the skin will be presented, as well as aspects of topical formulation that are significantly different from other dosage forms and pitfalls to avoid in the development of semi-solid products. Techniques for enhancing skin penetration and targeting hair follicles will be discussed, and in vitro skin permeation techniques will be critically reviewed. Emphasis will be placed on development issues and decisions that managers will face, such as when to develop the final to-be-marketed formulation, advantages of off-shore clinical development, and bridging strategies for formulation changes. Practical guidance for preclinical, CMC and clinical product development will be provided. The regulatory pathway for dermatological products will be reviewed as will the unique aspects of semi-solid patents and the FDA's Dermatology and Dental Division.
Dr. David Osborne directs Formulation Development and the In Vitro Penetration and Drug Delivery Laboratory at Dow Pharmaceutical Sciences, Inc. www.dowpharmsci.com, a company that specializes in topical drug product development. David has 25 issued patents and 45 publications, and was editor of the book "Topical Drug Delivery Formulations". He is a member of the American Academy of Dermatology, the American Academy of Pharmaceutical Scientists, the Society for Investigative Dermatology, and the American Chemical Society. David holds a PhD in physical chemistry from the University of Missouri-Rolla and a BS in chemistry from Missouri State University, and received the 2001 Missouri State University Outstanding Young Alumni award. Dr. Osborne joined the advisory board for the Missouri State University Chemistry Department in 2003. Proceeds from his upcoming course at Missouri State will go to the school's Board of Advisors Fund.
For more information on the dermatological product development course please visit: http://www.dowpharm.com/derm-product-dev-r1.asp or call Steve Smith, with Dow Pharmaceutical Sciences, Inc. at (707) 665-4672.
About Missouri State University
The Missouri State University system enrolls 21,000 students and offers 43 graduate programs, many of which are the state's strongest and largest of their kind. Nearly 90 percent of the University's 700 full-time faculty members have a doctorate or the highest degree in their field.
About Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. www.dowpharmsci.com, specializes in development of topical drug products for pharmaceutical and biotechnology clients. They offer a full range of product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art skin penetration laboratory tools, analytical and stability support, and cGMP manufacturing and labeling of clinical trial materials. Dow conducts dermatology trials at its two clinical sites in California and provides full dermatology CRO services in Europe through its Bioskin subsidiary headquartered in Hamburg, Germany. Dow Pharmaceutical Sciences, Inc. supports all aspects of regulatory development, including FDA meeting support and document preparation and submissions. In 2005 Dow had two electronic NDA's approved by the FDA, Clobex(R) Spray and Metrogel(R) Topical Gel 1%. Both products are marketed by Galderma Labs.
The Dow Pharmaceutical Sciences, Inc. company logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2408